本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vera Therapeutics, Inc.

31.77
-1.9000-5.64%
盤前32.000.2300+0.72%04:01 EDT
成交量:391.19萬
成交額:1.25億
市值:22.78億
市盈率:-5.39
高:34.00
開:33.22
低:31.19
收:33.67
52周最高:56.05
52周最低:23.05
股本:7,171.39萬
流通股本:5,239.41萬
量比:1.03
換手率:7.47%
股息:- -
股息率:- -
每股收益(TTM):-5.8984
每股收益(LYR):-4.6644
淨資產收益率:-91.75%
總資產收益率:-46.76%
市淨率:5.59
市盈率(LYR):-6.81

資料載入中...

2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/29

重要事件披露

Form 8-K - Current report
2024/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report